-
Mashup Score: 5How a “Netflix Model” Can Help States Pay for Hepatitis C Treatment - Drug Pricing Lab - 1 year(s) ago
Dr. Peter B, Bach, Director of Memorial Sloan Kettering’s Dug Pricing Lab, and co-authors Mark R. Trusheim of MIT and Dr, William Cassidy, former governor of Louisiana and a United States Senator, developed a new approach to pay for the life-saving drugs for Hepatitis C at an affordable or discounted price.
Source: www.drugpricinglab.orgCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 2Vanderbilt’s Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute - 1 year(s) ago
Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), has been named director of the National Cancer Institute
Source: news.vumc.orgCategories: General Medicine News, General HCPsTweet-
What a terrific way to start out a Friday. @VUMChealth @theNCI https://t.co/EulyoLKXOh
-
-
Mashup Score: 2Vanderbilt’s Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute - 1 year(s) ago
Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), has been named director of the National Cancer Institute
Source: news.vumc.orgCategories: General Medicine News, General HCPsTweet-
What a terrific way to start out a Friday. @VUMChealth @theNCI https://t.co/EulyoLKXOh
-
-
Mashup Score: 22Forward Therapeutics Announces $50 Million Series A Financing - Forward Therapeutics - 1 year(s) ago
Announcing Series A financing led by BVF Partners, RA Capital and Orbimed.
Source: forward-tx.comCategories: General Medicine News, General HCPsTweet-
Well look what happened. An exciting new biotech working on small molecule therapies had a big raise. Maybe the IRA didn’t actually kill innovation in small molecules? https://t.co/YBYP0oxuLe
-
-
Mashup Score: 2Delfi launches its blood test to screen for lung cancer – and reveals challenges for liquid biopsies - 1 year(s) ago
Taking aim at a major killer, the well-funded startup Delfi Diagnostics launches a blood test to screen for lung cancer.
Source: www.statnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Liquid biopsy for lung cancer is launched by Delfi - STAT TY @statnews @matthewherper for the discussion of @DELFIDiagnostic FirstLook. Appreciate my colleagues who weighed in with their thoughts on this public health oppty. https://t.co/n7jrxHVYOr
-
-
Mashup Score: 2
A new study says that most cancer screening doesn’t save lives. But proving that kind of negative isn’t just hard — it’s impossible.
Source: www.statnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
https://t.co/TumVHfGFXs https://t.co/dfkKspH7DP
-
-
Mashup Score: 5
A new study says that most cancer screening doesn’t save lives. But proving that kind of negative isn’t just hard — it’s impossible.
Source: www.statnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
TY @statnews I make two nerdy points: 1) Cancer screening has hard math vis-a-vis benefits vs harms 2) Last week's study with its booming conclusion that screening does not lengthen life is, at best, frail; for sure, misinterpreted; at worst, tilted. 1/n https://t.co/TumVHfHdN0
-
-
Mashup Score: 0
Original Article from The New England Journal of Medicine — Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Source: www.nejm.orgCategories: Healthcare Professionals, Latest HeadlinesTweet-
For lung cancer screening studies (@DELFIDiagnostic where I work, we are developing a lung cancer screening blood test), they exclude the NLST study. Wut? Their 'exclusion' reason they then contradict including the PLCO and Mandel CRC studies. Wut^2. 5/n https://t.co/MHHWuZP7JJ
-
-
Mashup Score: 0Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis - 1 year(s) ago
Benefit of lung cancer screening using low-dose computed tomography (LDCT) in reducing lung cancer–specific and all-cause mortality is unclear. We undertook a meta-analysis to assess its associations with outcomes.We searched the literature and …
Source: www.ncbi.nlm.nih.govCategories: Healthcare Professionals, Latest HeadlinesTweet-
@DELFIDiagnostic SMH. Even tho lung screening studies not designed to see if it increased lifespan overall, including the NLST using their methods makes it quite likely (> 80% probability) that it does. This matches Ebell et al. results the authors don't even cite. 6/n https://t.co/vh3ZTrpbSF
-
-
Mashup Score: 1
A new study says that most cancer screening doesn’t save lives. But proving that kind of negative isn’t just hard — it’s impossible.
Source: www.statnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
The (many) problems with a new study criticizing cancer screening Ty @statnews for providing me space to explain why the question the authors asked is important and why their answer is unsupportable, and likely incorrect. https://t.co/TumVHfGFXs
-
TY WH/Dr. Collins for pursuing subscription based model for Hepatitis C elimination (and for the shoutout to our work). Approach fixes a mkt failure and may greatly reduce burden from disease. Here is some history of the approach: https://t.co/5UcUWQBipf https://t.co/B2T4w3hloA